Whole Exome Sequencing now available for Cardiology
Transgenomic, Inc. now offers Whole Exome Sequencing for Cardiology patients with suspected inherited arrhythmia syndromes and other cardiovascular disorders. Whole Exome Sequencing (WES) is a genetic testing approach to consider when routine genetic testing has not identified a disease-causing mutation and family members are available for testing to help elucidate the clinical significance of novel variants. WES is a complementary addition to the FAMILION menu of genetic tests for cardiovascular disorders.
New Pathology and Cytogenetic Products
Transgenomic is now a distributor for Applied Spectral Imaging’s GenASIs product line in Europe. The GenASIs products offer a wide range of capabilities for pathology, cytogenetic and research applications. Transgenomic is now a distributor for Intregrated Systems Engineering’s Galileo product line in the U.S. and limited countries in Europe. Galileo Tissue Microarray Instruments provide pathologists with semi-automated to fully-automated solutions for TMA design and reporting.